Entasis Therapeutics Holdings Inc (ETTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 0 | 0 | 7,000 | 5,000 | 0 |
| Gross Profit | N/A | N/A | 7,000 | 5,000 | N/A |
| Operating Expenses | 52,317 | 54,231 | 53,936 | 43,207 | 31,344 |
| Operating Income | -52,317 | -54,231 | -46,936 | -38,207 | -31,344 |
| Other Income | 5,176 | 3,735 | 3,763 | 5,727 | 1,421 |
| Pre-tax Income | -47,141 | -50,496 | -43,173 | -32,480 | -29,923 |
| Income Tax | N/A | N/A | 677 | 472 | N/A |
| Net Income Continuous | -47,141 | -50,496 | -43,850 | -32,952 | -29,923 |
| Net Income | $-47,141 | $-50,496 | $-43,850 | $-32,952 | $-29,923 |
| EPS Basic Total Ops | -1.09 | -2.10 | -3.33 | -12.31 | -13,795.76 |
| EPS Basic Continuous Ops | -1.09 | -2.10 | -3.33 | -9.64 | -13,795.76 |
| EPS Diluted Total Ops | -1.09 | -2.10 | -3.33 | -12.31 | -13,795.76 |
| EPS Diluted Continuous Ops | -1.09 | -2.10 | -3.33 | -9.64 | -13,795.76 |
| EPS Diluted Before Non-Recurring Items | -1.09 | -2.10 | -3.33 | -12.31 | N/A |
| EBITDA(a) | $-52,213 | $-54,127 | $-47,480 | $-38,064 | $-31,150 |